Ascentage Limited - Net Worth and Insider Trading

Ascentage Limited Net Worth

The estimated net worth of Ascentage Limited is at least $2.4 Billion dollars as of 2025-04-12. Ascentage Limited is the of Ascentage Pharma Group International and owns about 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) stock worth over $2.4 Billion. Details can be seen in Ascentage Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ascentage Limited has not made any transactions after 2023-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ascentage Limited

To

Ascentage Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ascentage Limited owns 1 companies in total, including Ascentage Pharma Group International (HKSE:06855) .

Click here to see the complete history of Ascentage Limited’s form 4 insider trades.

Insider Ownership Summary of Ascentage Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:06855 Ascentage Pharma Group International 2023-10-27

Ascentage Limited Latest Holdings Summary

Ascentage Limited currently owns a total of 1 stock. Ascentage Limited owns 64,585,929 shares of Ascentage Pharma Group International (HKSE:06855) as of October 27, 2023, with a value of $2.4 Billion.

Latest Holdings of Ascentage Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06855 Ascentage Pharma Group International 2023-10-27 64,585,929 37.05 2,392,908,669

Holding Weightings of Ascentage Limited


Ascentage Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Ascentage Limited has made a total of 10 transactions in Ascentage Pharma Group International (HKSE:06855) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Ascentage Pharma Group International is the sale of 0 shares on October 27, 2023, which brought Ascentage Limited around $0.

Insider Trading History of Ascentage Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ascentage Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ascentage Limited Ownership Network

Ownership Network List of Ascentage Limited

No Data

Ownership Network Relation of Ascentage Limited

Insider Network Chart

Ascentage Limited Owned Company Details

What does Ascentage Pharma Group International do?

Who are the key executives at Ascentage Pharma Group International?

Ascentage Limited is the of Ascentage Pharma Group International. Other key executives at Ascentage Pharma Group International include 2201 Interest of corporation controlled by you JPMorgan Chase & Co. , 2201 Interest of corporation controlled by you Takeda Pharmaceuticals Company Limited , and 2101 Beneficial owner Takeda Pharmaceuticals International AG .

Ascentage Pharma Group International (HKSE:06855) Insider Trades Summary

Over the past 18 months, Ascentage Limited made no insider transaction in Ascentage Pharma Group International (HKSE:06855). Other recent insider transactions involving Ascentage Pharma Group International (HKSE:06855) include a net sale of 0 shares made by JPMorgan Chase & Co. , a net sale of 0 shares made by Zhai Yifan , and a net purchase of 24,307,322 shares made by Takeda Pharmaceuticals International AG .

In summary, during the past 3 months, insiders sold 0 shares of Ascentage Pharma Group International (HKSE:06855) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ascentage Pharma Group International (HKSE:06855) were sold and 48,614,644 shares were bought by its insiders, resulting in a net purchase of 48,614,644 shares.

Ascentage Pharma Group International (HKSE:06855)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ascentage Pharma Group International Insider Transactions

No Available Data

Ascentage Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Ascentage Limited. Currently GuruFocus does not have mailing address information for Ascentage Limited.